Strive has increased its Bitcoin holdings by acquiring 2,822 BTC for $235 million, bringing its total to 35,595 BTC. This purchase pushes Strive ahead of MARA Holdings, which now holds 35,577 BTC after a recent sale, making Strive the fourth-largest corporate Bitcoin holder. With Bitcoin priced around $82,000, Strive's Bitcoin treasury is valued at approximately $2.9 billion. Additionally, Strive has seen strong warrant exercises, raising $369 million in gross proceeds, indicating robust investor confidence.
Strive's recent Bitcoin accumulation contrasts with the broader cryptocurrency market's decline. As of Oct 14, 2026 21:02 WIB, only 6 out of 50 major cryptocurrencies on Pluang rose, while 43 fell. Among notable movers, XLM dropped 3.33% with a 66% buy order activity, AVAX decreased 3.08% with a nearly balanced sell/buy split, and KSM fell 3.07% with 90% sell orders and a typical hold time of 80 days.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
